Amrize Recommends Shareholders Reject Mini-Tender Offer By TRC Capital Investment Corporation
Amrize (NYSE: AMRZ) has issued a strong recommendation against TRC Capital Investment Corporation's unsolicited mini-tender offer to purchase up to 2 million ordinary shares at $49.63 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Amrize does not endorse TRC’s unsolicited mini-tender offer and recommends that Amrize shareholders do not tender their Ordinary Shares in the offer because the offer is at a price below the current market price for the Ordinary Shares.
TRC has included in the terms of its offer a condition that the closing price of the Ordinary Shares must not decrease by more than
Shareholders should obtain current market quotations for their shares, consult with their broker or financial advisor, and exercise caution with respect to TRC’s mini-tender offer.
Amrize recommends that shareholders who have not responded to TRC’s offer take no action. Shareholders who have already tendered their Ordinary Shares may withdraw them at any time prior to 11:59 p.m.
Mini-tender offers seek to acquire less than five percent of a company's outstanding shares. Consequently, they can avoid many disclosure and procedural requirements of
Amrize encourages brokers and dealers, as well as other market participants, to review the SEC's letter regarding broker-dealer mini-tender offer dissemination and disclosure available at https://www.sec.gov/divisions/marketreg/minitenders/sia072401.htm.
Amrize requests that a copy of this news release be included with all distributions of materials relating to TRC’s mini-tender offer for the Ordinary Shares.
About Amrize
Amrize (NYSE: AMRZ) is building
Learn more at amrize.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250828959593/en/
Media Relations:
media@amrize.com
Investor Relations:
investors@amrize.com
Source: Amrize Ltd